Clark Estates Inc’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.72M | Hold |
96,750
| – | – | 0.65% | 26 |
|
|
2025
Q4 | $2.41M | Buy |
96,750
+7,200
| +8% | +$182K | 0.58% | 37 |
|
|
2025
Q3 | $2.28M | Buy |
89,550
+8,000
| +10% | +$197K | 0.52% | 43 |
|
|
2025
Q2 | $1.98M | Hold |
81,550
| – | – | 0.44% | 40 |
|
|
2025
Q1 | $2.07M | Buy |
+81,550
| New | +$2.13M | 0.44% | 41 |
|
|
2024
Q1 | – | Sell |
-123,025
| Closed | -$3.54M | – | 92 |
|
|
2023
Q4 | $3.54M | Sell |
123,025
-84,700
| -41% | -$2.56M | 0.6% | 38 |
|
|
2023
Q3 | $6.89M | Buy |
207,725
+13,800
| +7% | +$488K | 1.25% | 16 |
|
|
2023
Q2 | $7.11M | Buy |
193,925
+9,450
| +5% | +$368K | 1.2% | 15 |
|
|
2023
Q1 | $7.53M | Buy |
184,475
+23,545
| +15% | +$1.02M | 1.49% | 15 |
|
|
2022
Q4 | $8.25M | Sell |
160,930
-5,460
| -3% | -$262K | 1.71% | 12 |
|
|
2022
Q3 | $7.28M | Hold |
166,390
| – | – | 1.61% | 13 |
|
|
2022
Q2 | $8.72M | Sell |
166,390
-30,000
| -15% | -$1.53M | 1.51% | 18 |
|
|
2022
Q1 | $10.2M | Sell |
196,390
-193,185
| -50% | -$10M | 1.6% | 18 |
|
|
2021
Q4 | $23M | Sell |
389,575
-140,000
| -26% | -$6.94M | 3.37% | 5 |
|
|
2021
Q3 | $22.8M | Hold |
529,575
| – | – | 3.25% | 6 |
|
|
2021
Q2 | $20.7M | Buy |
529,575
+196,850
| +59% | +$7.66M | 2.71% | 9 |
|
|
2021
Q1 | $12.1M | Sell |
332,725
-7,500
| -2% | -$266K | 1.54% | 17 |
|
|
2020
Q4 | $12.5M | Sell |
340,225
-30,309
| -8% | -$1.11M | 1.77% | 15 |
|
|
2020
Q3 | $12.9M | Hold |
370,534
| – | – | 2.11% | 11 |
|
|
2020
Q2 | $11.5M | Buy |
370,534
+42,635
| +13% | +$1.45M | 2.01% | 13 |
|
|
2020
Q1 | $10.2M | Hold |
327,899
| – | – | 2.07% | 10 |
|
|
2019
Q4 | $12.2M | Hold |
327,899
| – | – | 1.86% | 15 |
|
|
2019
Q3 | $11.2M | Sell |
327,899
-13,702
| -4% | -$498K | 1.84% | 14 |
|
|
2019
Q2 | $14M | Sell |
341,601
-26,350
| -7% | -$1.05M | 2.24% | 13 |
|
|
2019
Q1 | $14.8M | Sell |
367,951
-107,103
| -23% | -$4.29M | 2.3% | 14 |
|
|
2018
Q4 | $19.7M | Sell |
475,054
-387,302
| -45% | -$16.1M | 3.15% | 8 |
|
|
2018
Q3 | $36.1M | Sell |
862,356
-393,248
| -31% | -$15.1M | 5.41% | 2 |
|
|
2018
Q2 | $43.2M | Sell |
1,255,604
-7,072
| -0.6% | -$242K | 6.46% | 1 |
|
|
2018
Q1 | $42.5M | Sell |
1,262,676
-150,090
| -11% | -$5.16M | 6.79% | 1 |
|
|
2017
Q4 | $48.5M | Sell |
1,412,766
-316,200
| -18% | -$10.8M | 8.02% | 1 |
|
|
2017
Q3 | $58.6M | Sell |
1,728,966
-115,119
| -6% | -$3.7M | 9.72% | 1 |
|
|
2017
Q2 | $58.8M | Hold |
1,844,085
| – | – | 10.1% | 1 |
|
|
2017
Q1 | $59.9M | Buy |
1,844,085
+81,000
| +5% | +$2.55M | 9.21% | 2 |
|
|
2016
Q4 | $54.3M | Buy |
1,763,085
+727,260
| +70% | +$22.2M | 9.15% | 2 |
|
|
2016
Q3 | $33.3M | Sell |
1,035,825
-26,497
| -2% | -$886K | 6.43% | 2 |
|
|
2016
Q2 | $35.5M | Sell |
1,062,322
-52,700
| -5% | -$1.68M | 7.04% | 1 |
|
|
2016
Q1 | $31.4M | Buy |
1,115,022
+389,505
| +54% | +$11.1M | 6% | 4 |
|
|
2015
Q4 | $22.2M | Sell |
725,517
-44,900
| -6% | -$1.41M | 4.01% | 5 |
|
|
2015
Q3 | $23M | Hold |
770,417
| – | – | 3.95% | 5 |
|
|
2015
Q2 | $24.5M | Sell |
770,417
-140
| -0% | -$4.56K | 3.96% | 6 |
|
|
2015
Q1 | $25.4M | Buy |
770,557
+166,005
| +27% | +$5.28M | 4.11% | 6 |
|
|
2014
Q4 | $17.9M | Hold |
604,552
| – | – | 2.68% | 12 |
|
|
2014
Q3 | $17M | Hold |
604,552
| – | – | 2.71% | 11 |
|
|
2014
Q2 | $17M | Hold |
604,552
| – | – | 2.43% | 13 |
|
|
2014
Q1 | $18.4M | Hold |
604,552
| – | – | 2.77% | 12 |
|
|
2013
Q4 | $17.6M | Hold |
604,552
| – | – | 2.49% | 10 |
|
|
2013
Q3 | $16.5M | Buy |
604,552
+1,475
| +0.2% | +$40.1K | 2.5% | 11 |
|
|
2013
Q2 | $16M | Buy |
+603,077
| New | +$16.7M | 2.76% | 7 |
|
Other funds holding PFE
VCM
VPM
Clark Estates Inc's PFE Position: Q1 2026 in Review
Clark Estates Inc held its Pfizer (PFE) position steady in Q1 2026 at 96,750 shares worth $2.72M. The position accounts for 0.65% of the portfolio, ranked #26.
Clark Estates Inc first reported a position in PFE in Q2 2013 and has held it in 48 quarters since. The position peaked at $59.9M in Q1 2017. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Clark Estates Inc held 96,750 shares of Pfizer worth $2.72M as of Q1 2026.
- Clark Estates Inc left its Pfizer share count unchanged in Q1 2026.
- Pfizer made up 0.65% of Clark Estates Inc's portfolio in Q1 2026, its #26 holding.
- Clark Estates Inc first reported a position in Pfizer in Q2 2013 and has held it in 48 quarters since.
- Clark Estates Inc's Pfizer position peaked at $59.9M in Q1 2017.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Clark Estates Inc's 13F filing for Q1 2026, filed 11 May 2026.